bacteriostatic 0.9% sodium chloride

Bacteriostatic 0.9% Sodium Chloride is a sterile, nonpyrogenic, isotonic solution of sodium chloride (9 mg/mL) in water for injection, containing 0.9% (9 mg/mL) benzyl alcohol as a bacteriostatic preservative. It is primarily indicated as a diluent or vehicle for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection. In clinical trials, such as a Phase 4 study (NCT01459666) sponsored by University Hospitals Cleveland Medical Center, it has been utilized as a placebo control and reconstitution vehicle for abobotulinumtoxinA (Dysport) to evaluate wound healing and scar (cicatrix) outcomes following Mohs micrographic surgery. It has no active pharmacological ingredients or specific biological targets of its own.

Other names

Bacteriostatic 0.9% Sodium Chloride (vehicle)Bacteriostatic 0.9% Sodium Chloride Injectionbacteriostatic salinebacteriostatic sodium chloride